Delivery Order SPE2DB22D3004-SPE2DB26FQ89C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,723.72 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride 100 mL vials. Issued on September 12, 2025, with an ultimate completion date of September 15, 2025, this firm fixed-price delivery order represents a competitively awarded non-set-aside contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,029.56 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tranexamic 1,000 mg/100ml with Sodium Chloride 100ml, with an ultimate completion date of September 18, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,017.52 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1000mg in quantities of 10 units. This non-set-aside, competitively awarded contract was issued on May 28, 2025, with an ultimate completion date of May 29, 2025, reflecting expedited delivery requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Tranexamic Acid 1,000 mg/10 mL in 10 mL vials, with a contract ceiling value of $1,801.51 and a firm fixed price structure. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and does not include a set-aside designation. This delivery order represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,406.72 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tranexamic 1,000 mg/100mL sodium chloride solution in 100mL units. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with an ultimate completion date of August 8, 2025. The work will be performed at the awardee's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 3, 2025, for Tranexamic 1,000 mg/100ml-NaCl 100ml pharmaceutical supplies, with a ceiling value of $1,202.94 and firm fixed pricing. The delivery order is not set-aside and is scheduled for ultimate completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tranexamic 1,000 mg/100 mL in 100 mL saline solution vials. This is a firm fixed-price delivery order valued at $2,039.66, with an ultimate completion date of September 25, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The order, valued at $4,603.22, is for the supply of 4,564,043,690 units of the medication Tranexamic Acid 1,000 mg/100 mL-Sodium Chloride 100 mL. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This delivery order awards AmerisourceBergen Drug Corp a $2,127.53 firm fixed-price contract for Tranexamic Acid 1,000 mg/10 mL vials, with performance completion scheduled for July 22, 2025. The Defense Logistics Agency, under its medical supply chain operations, issued this non-set-aside competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing at its corporate office location. This delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $64,630 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100mL bottles of tranexamic acid. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 10 bottles of the pharmaceutical product. Performance will take place in Conshohocken, Pennsylvania by July 20, 2023. No subcontractors or set-aside designations were identified. The...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ89CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,489.51 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride solution (100 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, and performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Tranexamic acid, the product being delivered under this order, is a hemostatic agent commonly used in medical settings to control bleeding, reflecting the critical nature of pharmaceutical supply chains supporting defense and military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/5/25 |